Novel combination therapy with imiquimod and sorafenib for renal cell carcinoma

KARASHIMA Takashi; KOMATSU Toshihiro; NIIMURA Mayumi; KAWADA Chiaki; KAMADA Masayuki; INOUE Keiji; UDAKA Keiko; KURODA Naoto; SHUIN Taro

Art

J-GLOBAL ID：201402271720875891 Reference number：14A0962787

Novel combination therapy with imiquimod and sorafenib for renal cell carcinoma

腎細胞癌に対するイミキモドとソラフェニブの新規併用療法

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=14A0962787&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0962787&from=J-GLOBAL&jstjournalNo=W1347A") }}

Author (9)： , , , , , , , ,
Material：
Volume： 21 Issue： 7 Page： 702-706 Publication year： Jul. 2014
JST Material Number： W1347A ISSN： 0919-8172 Document type： Article
Article type：原著論文 Country of issue： Australia (AUS) Language： ENGLISH (EN)

,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0962787&from=J-GLOBAL&jstjournalNo=W1347A") }}

Basic research of immunotherapeutic agents and blood preparations , Basic research of antitumor(=antineoplastic)drugs

Reference (29)：

Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 2008; 113: 78-83.
Escudier B, Eisen T, Stadler WM et al.; TARGET Study Group. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl. J. Med. 2007; 356: 125-34.
Motzer RJ, Hutson TE, Tomczak P et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N. Engl. J. Med. 2007; 356: 115-24.
Naito S, Tomita Y, Rha SY et al. Kidney Cancer Working Group report. Jpn. J. Clin. Oncol. 2010; 40: 51-6.
Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat. Rev. 2008; 34: 193-205.

ｍore...

, , ,

Return to Previous Page